STOCK TITAN

OptimizeRx to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

OptimizeRx Corp (Nasdaq: OPRX), a healthcare technology solutions provider, has announced its participation in two upcoming investor conferences in New York City. The company will attend the 13th Annual ROTH Technology Conference from November 19th-20th, 2024, at The Hard Rock Hotel, and Canaccord Genuity's 2024 CG MedTech, Diagnostics and Digital Health & Services Forum on November 21st, 2024, at The Westin NY Grand Central. Both events will feature one-on-one meeting formats with management.

OptimizeRx Corp (Nasdaq: OPRX), un fornitore di soluzioni tecnologiche per la salute, ha annunciato la sua partecipazione a due prossimi conferenze per investitori a New York City. L'azienda parteciperà al 13° Annual ROTH Technology Conference dal 19 al 20 novembre 2024, presso il Hard Rock Hotel, e al 2024 CG MedTech, Diagnostics and Digital Health & Services Forum di Canaccord Genuity il 21 novembre 2024, al Westin NY Grand Central. Entrambi gli eventi presenteranno incontri one-on-one con il management.

OptimizeRx Corp (Nasdaq: OPRX), un proveedor de soluciones tecnológicas de salud, ha anunciado su participación en dos próximas conferencias de inversores en Nueva York. La empresa asistirá a la 13ª Conferencia Anual de Tecnología ROTH del 19 al 20 de noviembre de 2024, en el Hard Rock Hotel, y al Foro de MedTech, Diagnósticos y Salud Digital & Servicios 2024 de Canaccord Genuity el 21 de noviembre de 2024, en el Westin NY Grand Central. Ambos eventos contarán con formatos de reuniones uno a uno con la gerencia.

OptimizeRx Corp (Nasdaq: OPRX)는 헬스케어 기술 솔루션 제공업체로서 뉴욕시에서 열리는 두 개의 투자자 컨퍼런스에 참여한다고 발표했습니다. 이 회사는 2024년 11월 19일부터 20일까지 제13회 연례 ROTH 기술 컨퍼런스에 참석할 예정이며, 2024년 11월 21일에는 Canaccord Genuity의 2024 CG MedTech, Diagnostics and Digital Health & Services Forum에 참여할 예정입니다. 두 이벤트 모두 경영진과의 일대일 미팅 형식이 진행될 예정입니다.

OptimizeRx Corp (Nasdaq: OPRX), un fournisseur de solutions technologiques pour la santé, a annoncé sa participation à deux prochaines conférences pour investisseurs à New York. L'entreprise assistera à la 13e Conférence Technologique Annuelle ROTH du 19 au 20 novembre 2024, à l'Hôtel Hard Rock, et au Forum 2024 CG MedTech, Diagnostics et Santé Numérique & Services de Canaccord Genuity le 21 novembre 2024, au Westin NY Grand Central. Les deux événements proposeront des rencontres en tête-à-tête avec la direction.

OptimizeRx Corp (Nasdaq: OPRX), ein Anbieter von Technologie-Lösungen im Gesundheitswesen, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen in New York City bekannt gegeben. Das Unternehmen wird an der 13. jährlichen ROTH-Technologiekonferenz vom 19. bis 20. November 2024 im Hard Rock Hotel teilnehmen und am 2024 CG MedTech, Diagnostics and Digital Health & Services Forum von Canaccord Genuity am 21. November 2024 im Westin NY Grand Central teilnehmen. Beide Veranstaltungen umfassen Einzelgespräche mit dem Management.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences: 

  • 13th Annual ROTH Technology Conference, New York City, November 19th – 20th, 2024
  • Canaccord Genuity’s 2024 CG MedTech, Diagnostics and Digital Health & Services Forum, New York City, November 21st, 2024

Conference Details: 

13th Annual ROTH Technology Conference
Date: Tuesday, November 19th – Wednesday 20th
Format:1x1 Meetings
Location:The Hard Rock Hotel, New York City

Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
Date: Thursday, November 21st
Format:1x1 Meetings
Location:The Westin NY Grand Central, New York City


To request a meeting or for more details about the conferences please reach out to your institutional contact or email.

About OptimizeRx 
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 2 million U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, as well as mass digital communication channels, OptimizeRx helps life sciences organizations engage and support their customers.

For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.  

OptimizeRx Contact  
Andy D’Silva, SVP Corporate Finance 
adsilva@optimizerx.com 

Investor Relations Contact 
Ashley Robinson 
LifeSci Advisors, LLC 
arr@lifesciadvisors.com 


FAQ

Which investor conferences will OptimizeRx (OPRX) attend in November 2024?

OptimizeRx will attend the 13th Annual ROTH Technology Conference (Nov 19-20) and Canaccord Genuity's 2024 CG MedTech, Diagnostics and Digital Health & Services Forum (Nov 21) in New York City.

Where will the ROTH Technology Conference featuring OptimizeRx (OPRX) be held in 2024?

The 13th Annual ROTH Technology Conference will be held at The Hard Rock Hotel in New York City.

What is the format of OptimizeRx's (OPRX) participation in the November 2024 conferences?

OptimizeRx will participate in one-on-one meetings format at both conferences.

When and where is the Canaccord Genuity Forum featuring OptimizeRx (OPRX)?

The Canaccord Genuity Forum will be held on Thursday, November 21st, 2024, at The Westin NY Grand Central in New York City.

OptimizeRx Corporation

NASDAQ:OPRX

OPRX Rankings

OPRX Latest News

OPRX Stock Data

74.39M
18.32M
13.35%
76.02%
4.98%
Health Information Services
Services-business Services, Nec
Link
United States of America
WALTHAM